In the current climate of political austerity, the personalisation agenda needs to be handled with care.
You’d have to have been living as a hermit on South Uist or paddling up the Amazon in a coracle to have missed the fact that personalisation has been big news for some time now, promising to radically shift the relationship between the service user and the services used. For some in the drugs field, personalisation has become about developing individual budgets – a way of cutting up the pie that ensures resources are allocated according to need and directly managed by the individual or their representative. For others,
personalisation has come to mean developing more effective mechanisms for care management, placing a client-directed care plan at the centre of the treatment experience.
Additional keyword: funding